The Effects of CYP2C19 Genotype on Proxies of SSRI Antidepressant Response in the UK Biobank

Selective serotonin reuptake inhibitors (SSRIs) are the most commonly used psychopharmaceutical treatment for major depressive disorder (MDD), but individual responses to SSRIs vary greatly. CYP2C19 is a key enzyme involved in the metabolism of several drugs, including SSRIs. Variations in the CYP2C...

Full description

Bibliographic Details

Main Authors:	Win Lee Edwin Wong, Chiara Fabbri, Benjamin Laplace, Danyang Li, Roos van Westrhenen, Cathryn M. Lewis, Gavin Stewart Dawe, Allan H. Young
Format:	Artigo
Language:	Inglês
Published:	MDPI AG 2023-09-01
Series:	Pharmaceuticals
Subjects:	pharmacogenetics cytochrome P450 treatment response antidepressants
Online Access:	https://www.mdpi.com/1424-8247/16/9/1277
Tags:	Add Tag No Tags, Be the first to tag this record!